Guest guest Posted June 28, 2006 Report Share Posted June 28, 2006 Volunteers needed for trial of vaccine NT Bureau, Chennai, June 28: Around 16 healthy and non-infected volunteers are needed for the Phase - 1 of HIV vaccine trial conducted at the Tuberculosis Research Centre (TRC). This trial is conducted to test the safety of the vaccine. The HIV vaccine trial is the second attempt in the country and is being done in collaboration with YRG care Centre, Indian Council of Medical Research(ICMR), National AIDS Control Organisation(NACO) and International AIDS Vaccine Initiative (IAVI). Speaking to mediapersons, P R Narayanan, director TRC, said the phase 1 trial consists of two groups with 16 volunteers each . They would be given low dosage and high dosage of the TBC M4 vaccine respectively. TBC M4 is a vaccine which has a recombinant of Modified Vaccine Anakara(MVA) which would help test HIV -1 subtype India. He said that the centre already had 16 volunteers on whom the trials had already started and there was a need for 16 more between the age of 18 and 50. There would be three injections of the vaccine at zero, first month and sixth month . The volunteers would have to visit 17 times during the 18- month trial and have 14 blood draws. Speaking about the current condition of screening for volunteers, he said that 33 (of whom 15 are women) were screened and 16 (8 women) enrolled, seven (three women) non- eligible and six (four women) ready for enrolment. According to Dr Suniti , director, YRG Care, only people belonging to the low risk groups had been selected for the phase 1 and people with hypertension and diabetes were not eligible for the trials. She said the volunteers were under the care of the government and if any complication arises during the trial they would be taken care of. Interested persons can contact V D Ramanathan, deputy director, Department of Pathology, TRC, at 28369650. http://newstodaynet.com/28jun/rf11.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.